Placeholder Banner

BIO Opens Registration for the 13th Annual World Congress on Industrial Biotechnology in San Diego

January 26, 2016

The Biotechnology Innovation Organization (BIO) opened registration today for the 2016 World Congress on Industrial Biotechnology. The conference will be held April 17-20, 2016 in San Diego, California.

“BIO is pleased to hold the world’s largest conference on industrial biotechnology again in one of the significant west coast hubs of the biotechnology industry, San Diego,” stated Brent Erickson, Executive Vice President, Industrial and Environmental at BIO.  “Programming will explore biotechnology’s impact on the entire value chain for advanced biofuels, biobased products, renewable chemicals, synthetic biology, algae and biobased consumer products.  Attendees will get a first-hand look into how biotechnology is bringing about transformative solutions to societal problems and building a robust, sustainable bioeconomy.  And  business leaders will have a chance to use BIO’s new up graded business partnering system.”    

BIO’s World Congress on Industrial Biotechnology brings together from across the globe business leaders, investors, academics and policymakers in the biofuels, biobased products, renewable chemicals, materials science, synthetic biology, food ingredients and biomass sectors. Industrial and environmental biotechnology is at the forefront of the biobased economy, generating good-paying jobs and making cleaner products and manufacturing processes.

BIO hosted around 1,200 attendees from 50 countries and 37 U.S. states at its 2015 World Congress in Montréal. Attendees in 2015 represented 725 companies and 40 percent were C-Suite and VP-level.  The event hosted 1,400 partnering meetings over its three-day span.

All programs at the World Congress on Industrial Biotechnology are open to attendance by members of the media. Complimentary media registration is available to editors and reporters working full time for print, broadcast or web publications with valid press credentials. For more information and to register, please visit

For more information on the conference, please visit  For assistance, please contact

Discover More
Washington, DC (November 20, 2020) – Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose…
"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes…
The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds. Announcing the new vision, mission and…